Forschungsinstitut Havelhöhe

Forschungsinstitut Havelhöhe (FIH) is a non-profit research institute based in Berlin, Germany, specializing in integrative and anthroposophic medicine. Associated with the Gemeinschaftskrankenhaus Havelhöhe, the institute conducts clinical trials, health services research, and epidemiological studies to evaluate holistic treatment approaches. A primary focus of the FIH is the "Network Oncology" registry, which provides long-term data on the efficacy and safety of mistletoe therapy in cancer patients. Additionally, the institute has been heavily involved in observational research regarding COVID-19 and chronic disease management. FIH aims to bridge the gap between conventional medical standards and complementary therapeutic practices through rigorous scientific evaluation.